Q-Line Biotech IPO
Q-Line Biotech IPO is an SME IPO raising ₹214 Cr at ₹326 – ₹343 a share. It listed on 29 May 2026 at ₹452, +31.8% against its issue price of ₹343, and trades at ₹715 today (+108.4% since issue). It was subscribed 119× in total.
119.3 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Source documents
What the issuer and the exchanges published. Everything else on this tab is read out of these.
Which institutions were allotted shares before bidding opened, and how many.
The issuer's own "basis of issue price": the earnings multiples it is asking for, and the peer companies it chose to compare itself against.
The full prospectus — business, financials, risk factors and litigation.
Read-out of the prospectus
A severity-ranked risk register with every item cited to its page, plus litigation counts and rupee exposure and related-party dealings, are being built from the prospectus above. We read prospectuses for current and upcoming issues — historical issues will not gain these sections.